Global Biopreservation Market Overview
Introduction:
The biopreservation market accounted for US$ 4.2 billion in 2020 and is estimated to be US$ 11.31 billion by 2030, and is anticipated to register a CAGR of 10.5%.
Biopreservation uses natural flora and its antibacterial products to preserve biological material. Biopreservation has played an essential role in the healthcare and food industry in safeguarding biological material or food products for a long time. Major drivers include
- Innovations in regenerative medicines.
- The increasing incidence of chronic diseases.
- Advances in drug discovery and development.
Human blood, tissues, cells, and organs can potentially treat damaged tissues and organs with long-term benefits. Clinical research, life science, and material research are the primary applications of biopreservation. The knowledge of human cells and tissues being utilized for further research and developing novel treatment therapies led to the advent of biobanking. Collecting, processing, and storing the samples and related data are the essential functions of the biopreservation market. It preserves biological samples such as tissues, cells, saliva, whole blood, plasma, urine, nucleic acid, organs, and other bodily fluids. The biopreservation market accounted for US$ 4.2 billion in 2020 and is estimated to be US$ 11.31 billion by 2030, and is anticipated to register a CAGR of 10.5%.
Global Biopreservation Market Dynamics
Rising number of biobanks
An increasing number of biobanks is expected to propel the growth of the biopreservation market over the forecast period. The rising expenditure on healthcare, growing demand for stem cell preservation, and awareness about its use in treating diseases are expected to drive the market's growth. Moreover, increasing awareness about personalized medicines and their applications contributes to the market's development. Technological advancements in biopreservation processes are also significant growth contributing factors to the target market. Advancements include a change in the formulation of hypothermic storage solutions, next-generation cryopreservation solutions, and design and integration with nanoscale technologies. These technological upgrades have led to the long-term preservation and banking of complex organs and tissues of high importance in regenerative medicine and organ transplantation.
However, the high cost of biopreservation equipment will hamper the market growth.
Global Biopreservation Market Segmentation
The biopreservation market is segmented based on type, biospecimen application, and region.
The target market has been classified as media and equipment based on type. The media subsegment has been further divided into sera. The equipment segment has been further divided into thawing equipment, alarms, and freezers. The biospecimen segment has been divided into human tissue, stem cells, and organs. Based on application, the biopreservation media and equipment market is segmented into Therapeutic applications, Research applications, Clinical trials, and other applications.
Regional Insights:
The biopreservation market accounted for US$ 4.2 billion in 2020 and is estimated to be US$ 11.35 billion by 2030, and is anticipated to register a CAGR of 10.5%. In the region, the Biopreservation market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North American market is driven by the rise in demand for the preservation of blood, solid tissue specimens, including paraffin-embedded or frozen bio-specimen of tumors, and other tissues, such as peripheral blood cells and bone marrow, along with stem cells-derived cord blood and its derivatives, across multiple research institutes, pathological centers, and hospitals. Favorable government regulations have also been observed in this region, which supports the sharing of biological samples.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Billion & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Type – Media and Equipment By Biospecimen – Human Tissue, Stem Cells, and Organs By Application – Therapeutic, Research, Clinical Trials, and Other Applications |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global biopreservation market report based on type, biospecimen, application, and region.
Biopreservation Market, By Region:
- North America
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- U.S.
- Canada
- Middle East & Africa
Global Biopreservation Market Key Players
The key players operating in the biopreservation market includes BioCision LLC, Thermo Fisher Scientic, Inc., BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd, Custom Biogenic Systems Inc., Lifeline Scientific Inc., Merck KGaA, Princeton CryoTech Inc., and VWR International.
Global Biopreservation Market Company Profile
- BioCision LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- BioLife Solutions Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cesca Therapeutics Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Core Dynamics Ltd
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Custom Biogenic Systems Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Lifeline Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Merck KGaA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Princeton CryoTech Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- VWR International
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Global Biopreservation Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings—Global Outlook for Biopreservation Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By Biospecimen
- Market Snippet, By Application
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Type 2020 – 2030, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Media
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Equipment
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Market Segmentation, By Biospecimen 2020 – 2030, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Human Tissue
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Stem Cells
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Organs
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Market Segmentation, By Application 2020 – 2030, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Therapeutic
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Research
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Clinical Trials
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Other Application
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Market, By Region, 2020 – 2030, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Biospecimen, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Biospecimen, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Biospecimen, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Biospecimen, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Biospecimen, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- BioCision LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- BioLife Solutions Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cesca Therapeutics Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Core Dynamics Ltd
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Custom Biogenic Systems Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Lifeline Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Merck KGaA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Princeton CryoTech Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- VWR International
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The global biopreservation market is segmented based on type, biospecimen, application, and region.
Rising number of the biobanks is the major factor driving growth of the global market
North America is dominating region in the global biopreservation market.
The biopreservation market is highly competitive and consists of a number of major players, including BioCision LLC, Thermo Fisher Scientic, Inc., BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd, Custom Biogenic Systems Inc., Lifeline Scientific Inc., Merck KGaA, Princeton CryoTech Inc., and VWR International.